Glucokinase (GCK) and other susceptibility genes for beta-cell dysfunction: the candidate approach.
There are well-documented examples in the literature of where determining the genetic aetiology of a disorder has provided insights into important regulatory pathways and protein interactions, and, more recently, has led to improved treatment options for patients. The studies of monogenic forms of b...
Հիմնական հեղինակներ: | Gloyn, A, Tribble, N, van de Bunt, M, Barrett, A, Johnson, P |
---|---|
Ձևաչափ: | Journal article |
Լեզու: | English |
Հրապարակվել է: |
2008
|
Նմանատիպ նյութեր
-
Prevalence of glucokinase (GCK) mutations in people with elevated fasting glucose levels: implications for clinical trials
: Gloyn, A, և այլն
Հրապարակվել է: (2007) -
Identification and functional characterisation of novel inactivating glucokinase mutations causing GCK-MODY in Slovakia
: Valentinova, L, և այլն
Հրապարակվել է: (2011) -
Identification of a novel beta cell glucokinase (GCK) promoter mutation (-71 G > C) which reduces promoter activity
: Gasperikova, D, և այլն
Հրապարակվել է: (2008) -
Activating glucokinase (GCK) mutations as a cause of medically responsive congenital hyperinsulinism: prevalence in children and characterisation of a novel GCK mutation.
: Christesen, H, և այլն
Հրապարակվել է: (2008) -
Identification of a Novel beta-Cell Glucokinase (GCK) Promoter Mutation (-71G > C) That Modulates GCK Gene Expression Through Loss of Allele-Specific Sp1 Binding Causing Mild Fasting Hyperglycemia in Humans
: Gasperikova, D, և այլն
Հրապարակվել է: (2009)